Madrigal Pharmaceuticals, Inc. (MDGL)
539.73
+37.26
(+7.42%)
USD |
NASDAQ |
May 06, 16:00
539.00
-0.73
(-0.14%)
After-Hours: 07:34
Madrigal Pharmaceuticals SG&A Expense (TTM) : 645.95M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Insmed, Inc. | 701.17M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |
| Eli Lilly & Co. | 11.56B |
| PTC Therapeutics, Inc. | 347.14M |
| Protagonist Therapeutics, Inc. | 33.12M |